<DOC>
	<DOCNO>NCT02716870</DOCNO>
	<brief_summary>Fructose-containing sugar implicate epidemic obesity , diabetes relate cardiometabolic disorder . This view support low quality evidence ecological observation , animal model , select human trial . Higher level evidence control trial prospective cohort study inconclusive . Whether sugar contribute cardiometabolic complication independent calorie remain unclear . To address uncertainty , investigator propose conduct series systematic review meta-analyses totality evidence control trial distinguish contribution fructose-containing sugar energy development marker cardiometabolic risk . The finding generate propose knowledge synthesis help improve health consumer inform evidence-based guideline improve health outcome educate healthcare provider patient , stimulate industry innovation , guide future research design .</brief_summary>
	<brief_title>Meta-analyses Effect Important Food Sources Sugars Cardiometabolic Risk Factors</brief_title>
	<detailed_description>Background : Sugars emerge one important public health concern . Attention focus particularly fructose-containing sugar ( fructose , sucrose , high fructose corn syrup , honey , etc ) , collectively indict driver various cardiometabolic complication . This special view rest unique metabolic endocrine response fructose . Unlike glucose , fructose thought bypass negative feedback control act unregulated substrate de novo lipogenesis impair satiety signal result weight gain . In support mechanism , animal model , low-quality ecological study , select human trial overfeed level exposure far beyond population intake report adverse metabolic effect sugar . Higher level evidence systematic review meta-analyses control trial , however , suggest effect sugar mediate excess calorie rather sugar per se . It remain unclear whether fructose-containing sugar contribute cardiometabolic complication independent calorie . Need propose research : High quality systematic review meta-analyses control trial represent high level evidence support dietary guideline public health policy development . As dietary guideline public health policy shift toward food dietary-pattern base recommendation , urgent need systematic review meta-analyses compare role different food source sugar development cardiometabolic disease . Objective : The investigator conduct series systematic review meta-analyses distinguish effect fructose-containing sugar energy measure cardiometabolic risk control trial . Design : Each systematic review meta-analysis conduct accord Cochrane Handbook Systematic Reviews Interventions report accord Preferred Reporting Items Systematic Reviews Meta-Analyses ( PRISMA ) . Data source : MEDLINE , EMBASE , The Cochrane Central Register Controlled Trials ( Clinical Trials ; CENTRAL ) search use appropriate search term supplement hand search reference include study . Study selection : The investigator include randomize non-randomized controlled trial &gt; = 7-days duration ass effect fructose-containing sugar ( fructose , sucrose , high fructose corn syrup , honey , etc ) measure cardiometabolic risk . To allow separation effect sugar energy , 4 trial design consider : ( 1 ) 'substitution ' trial , fructose-containing sugar add food beverage compare macronutrient source ( usually starch sugar ) energy match condition ; ( 2 ) 'addition ' trial , fructose-containing sugar supplement diet excess energy compare diet alone without excess energy ; ( 3 ) 'subtraction ' trial , energy fructose-containing sugar ( usually form sugars-sweetened beverage ) reduce displacing water and/or no-calorie low-calorie sweetener eliminate altogether background diet ; ( 4 ) 'ad libitum ' trial , energy fructose-containing sugar freely replace source energy ( usually complex carbohydrate fat ) without strict control either study food background diet . Trials categorize source fructose-containing sugar ( fruit , fruit juice , sugars-sweetened beverage , liquid meal replacement , dairy product , sweets/desserts/baked good , mixed source ) chi squared test use determine between-group difference . Data extraction : Two investigator independently extract relevant data ass risk bias use Cochrane Risk Bias Tool . All disagreement resolve consensus . Standard computation imputation use derive miss variance data . Outcomes : Five set outcome assess : ( 1 ) glycemic control ( glycated blood protein [ HbA1c , fructosamine , glycated albumin ] , fast glucose , fast insulin ) , ( 2 ) blood lipid ( Established therapeutic lipid target [ LDL-cholesterol , non-HDL-cholesterol , apolipoprotein B ( apo B ) , HDL-cholesterol , triglycerides ] ) , ( 3 ) blood pressure ( Systolic blood pressure diastolic blood pressure ) , ( 4 ) uric acid , ( 5 ) non-alcoholic fatty liver disease ( NAFLD ) ( intrahepatocellular lipid [ IHCL ] , alanine aminotransferase [ ALT ] , aspartate aminotransferase [ AST ] ) . Data synthesis : Mean difference pool use generic inverse variance method food source fructose-containing sugar . Random-effects model use even absence statistically significant between-study heterogeneity , yield conservative summary effect estimate presence residual heterogeneity . Fixed-effects model use &lt; 5 included study . Paired analyse apply crossover trial . Heterogeneity assess Cochran Q statistic quantify I2 statistic . To explore source heterogeneity , investigator conduct sensitivity analysis , study systematically remove . If &gt; =10 study , investigator also explore source heterogeneity priori subgroup analysis age ( child [ = &lt; 18 year age ] , adult ) , health status ( metabolic syndrome criterion , diabetes , overweight/ obese , healthy ) , comparator type , fructose- containing sugar form ( sucrose , high fructose corn syrup [ HFCS ] , honey , fructose ) , dose ( = &lt; 10 % energy , &gt; 10 % ) , baseline measurement , randomization , study design ( parallel , crossover ) , energy balance ( positive , neutral , negative ) , follow-up ( &lt; 8-weeks , &gt; =8-weeks ) , risk bias . Meta-regression analysis assess significance categorical continuous subgroup analysis . When &gt; =10 study available , publication bias investigate inspection funnel plot formal test use Egger Begg test . If publication bias suspect , investigator attempt adjust funnel plot asymmetry impute miss study data use Duval Tweedie trim fill method . Evidence Assessment : The strength evidence outcome assess use Grading Recommendations Assessment , Development Evaluation ( GRADE ) . Knowledge translation plan : The result disseminate interactive presentation local , national , international scientific meeting publication high impact factor journal . Target audience include public health scientific community interest nutrition , diabetes , obesity , cardiovascular disease . Feedback incorporate use improve public health message key area future research define . Applicant/Co-applicant Decision Makers network among opinion leader increase awareness participate directly committee member development future guideline . Significance : The propose project aid knowledge translation relate role dietary fructose-containing sugar important food source sugar development cardiometabolic disease , strengthen evidence-base guideline improve health outcome educate healthcare provider patient , stimulate industry innovation , guide future research design .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Trials human Oral fructosecontaining sugar intervention Presence adequate comparator ( substitution , addition , subtraction , ad libitum control ) Diet duration &gt; =7 day Viable outcome data Nonhuman trial Observational study IV parenteral fructosecontaining sugar Lack suitable comparator ( i.e . comparator arm contain substantial fructosecontaining sugar ) Diet duration &lt; 7 day No viable outcome data</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Systematic review meta-analysis</keyword>
	<keyword>Evidence-based medicine ( EBM )</keyword>
	<keyword>Evidence-based nutrition ( EBN )</keyword>
	<keyword>Clinical practice guideline</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Dietary sugar</keyword>
	<keyword>Fructose</keyword>
	<keyword>High fructose corn syrup</keyword>
	<keyword>Fruit</keyword>
	<keyword>Isocaloric</keyword>
	<keyword>Hypercaloric</keyword>
	<keyword>Cardiometabolic risk factor</keyword>
	<keyword>Triglycerides</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>Glycemic control</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Body weight</keyword>
	<keyword>Uric acid</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Fatty liver</keyword>
	<keyword>Fasting</keyword>
	<keyword>Postprandial</keyword>
</DOC>